Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 255

1.
2.

CMA guidelines concerning relationship of MDs and drug industry to be revised, board told.

Sullivan P.

CMAJ. 1993 Jan 15;148(2):273-5. No abstract available.

3.

The CMA's MD-drug industry guidelines offer advice, nothing more.

Woollard R.

CMAJ. 1991 Dec 1;145(11):1498-9. No abstract available.

4.

CMA guidelines on MD-drug industry relations part of international trend.

Williams JR.

CMAJ. 1992 Feb 1;146(3):386-8. No abstract available.

5.

Physicians and the pharmaceutical industry.

Canadian Medical Association.

CMAJ. 1992 Feb 1;146(3):388A-C. No abstract available.

6.

Guidelines on gifts to physicians from industry: an update.

American Medical Association. Council on Ethical and Judicial Affairs.

Food Drug Law J. 1992;47(4):445-58. No abstract available.

PMID:
11654909
7.

Guidelines for relationships between industry and the American College of Obstetricians and Gynecologists and its fellows. ACOG Committee Opinion No. 45.

American College of Obstetricians and Gynecologists [ACOG]. Committee on Ethics.

ACOG Comm Opin. 1985 Oct;No. 45:1 p. No abstract available.

PMID:
11660326
8.
9.

Ethical responsibilities of physicians in their dealings with pharmaceutical companies.

Royal College of Physicians and Surgeons of Canada. Biomedical Ethics Committee.

Ann R Coll Physicians Surg Can. 1990 Jan;23(1):45-8. No abstract available.

PMID:
11650305
10.

Guidelines for interactions with pharmaceutical companies.

American Medical Association. Resident Physicians Section.

JAMA. 1993 Sep 8;270(10):1250. No abstract available.

PMID:
11643149
11.
12.

Financial conflicts of interest in physicians' relationships with the pharmaceutical industry--self-regulation in the shadow of federal prosecution.

Studdert DM, Mello MM, Brennan TA.

N Engl J Med. 2004 Oct 28;351(18):1891-900. No abstract available.

PMID:
15509824
13.

Interactions of staff and residents with pharmaceutical industry: a survey of psychiatric training program policies.

Chakrabarti A, Fleisher WP, Staley D, Calhoun L.

Ann R Coll Physicians Surg Can. 2002 Dec;35(8 Suppl.):541-6.

PMID:
15015500
14.

Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach.

Coleman DL, Kazdin AE, Miller LA, Morrow JS, Udelsman R.

Acad Med. 2006 Feb;81(2):154-60.

PMID:
16436576
15.

Proposed guidelines for housestaff interaction with pharmaceutical companies.

Forrest DM, Ruedy J.

Ann R Coll Physicians Surg Can. 1993 Oct;26(5):291-3.

PMID:
15362243
16.

Psychiatry has dangerous alliance with drug companies.

Mosher LR.

Behav Healthc Tomorrow. 1999 Jun;8(3):6. No abstract available.

PMID:
11645352
17.

AMA's gift guidelines.

Conley RB.

Food Drug Cosmet Med Device Law Dig. 1993;10:19-27. No abstract available.

PMID:
11654936
18.

Industry relationships between physicians and professional medical associations: corrupt or essential?

Smith CD, MacFadyen B.

Surg Endosc. 2010 Feb;24(2):251-3. doi: 10.1007/s00464-009-0878-4.

PMID:
20087748
19.

The relationship between physicians and the pharmaceutical industry: a report of the Royal College of Physicians.

Royal College of Physicians.

J R Coll Physicians Lond. 1986 Oct;20(4):3-10. No abstract available.

PMID:
11643936
20.

Physicians and the pharmaceutical industry (update 1994). Canadian Medical Association.

[No authors listed]

CMAJ. 1994 Jan 15;150(2):256A-256F. English, French.

Supplemental Content

Support Center